Chunze Li Selected Research

Chunze Li Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2009
12	Neoplasms (Cancer) 01/2023 - 07/2008
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2020
6	Body Weight (Weight, Body) 11/2021 - 11/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 12/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 12/2019
2	Neutropenia 01/2022 - 01/2020
2	Infections 01/2022 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 12/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 12/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 12/2017
1	Cachexia 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2022
1	Lymphoma (Lymphomas) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Pathologic Complete Response 01/2021
1	COVID-19 01/2021
1	Uveal melanoma 01/2020
1	Lymphoid Leukemia 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2014
1	Sudden Infant Death (SID) 11/2013
1	Pain (Aches) 11/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2009
1	Dehydration (Water Stress) 01/2006
1	Hypersensitivity (Allergy) 11/2005

Drug/Important Bio-Agent (IBA)

10	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2016
8	polatuzumab vedotinIBA 04/2024 - 01/2020
8	Ado-Trastuzumab EmtansineIBA 01/2019 - 01/2016
7	Trastuzumab (Herceptin)FDA Link 04/2022 - 11/2013
6	Rituximab (Mabthera)FDA Link 04/2024 - 12/2019
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2005
4	pertuzumabIBA 04/2022 - 01/2019
4	venetoclaxIBA 01/2022 - 12/2019
3	Prednisone (Sone)FDA LinkGeneric 04/2024 - 01/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 01/2020
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
3	monomethyl auristatin EIBA 01/2020 - 12/2016
3	human ERBB2 proteinIBA 01/2019 - 01/2017
2	atezolizumabIBA 01/2023 - 09/2022
2	obinutuzumabIBA 01/2022 - 01/2020
2	Valine (L-Valine)FDA Link 01/2019 - 12/2016
2	CitrullineIBA 01/2019 - 12/2016
2	Lapatinib (GW572016)FDA Link 04/2018 - 12/2017
2	Capecitabine (Xeloda)FDA Link 04/2018 - 12/2017
2	taxaneIBA 12/2017 - 07/2008
2	AntibodiesIBA 12/2016 - 11/2013
1	Gemcitabine FDA Link 01/2023
1	giredestrantIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	guadecitabineIBA 09/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	AlbuminsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Bendamustine Hydrochloride FDA Link 12/2020
1	Endothelin B ReceptorIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	rucaparibIBA 01/2015
1	PF-4989216IBA 02/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2014
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	ThiophenesIBA 11/2011
1	OrexinsIBA 07/2009
1	peptide permeaseIBA 05/2009
1	EnzymesIBA 05/2009
1	CationsIBA 05/2009
1	Messenger RNA (mRNA)IBA 05/2009
1	KinesinsIBA 07/2008
1	PyrrolesIBA 07/2008
1	compound 30IBA 07/2008
1	Cytotoxins (Cytolysins)IBA 07/2008
1	LactonesIBA 01/2006
1	Simvastatin (Zocor)FDA LinkGeneric 01/2006
1	AcidsIBA 11/2005
1	zomepirac (Zomax)IBA 11/2005
1	GlucuronidesIBA 11/2005

Therapy/Procedure

8	Therapeutics 02/2024 - 02/2014
2	Subcutaneous Injections 04/2022 - 01/2021
2	Duration of Therapy 11/2021 - 01/2019
1	Drug Tapering 12/2016